Priyanka Kanth

Priyanka Kanth, MSCI, FACG, AGAF, MD

Languages spoken: English, Hindi

Academic Information

Departments Adjunct - Internal Medicine

Divisions: Gastroenterology

Academic Office Information

priyanka.kanth@hsc.utah.edu

Board Certification

  • American Board of Internal Medicine
  • American Board of Internal Medicine (Sub: Gastroenterology)

Research Interests

  • Colonic Polyps
  • Colon Cancer
  • Colorectal Cancer Genetics
  • Colorectal Neoplasms, Hereditary Nonpolyposis
  • Inflammatory Bowel Disease/Crohn's/Ulcerative Colitis

Dr. Priyanka Kanth received her Medical Degree from Kasturba Medical College in India. She obtained graduate training in Internal Medicine from St. Mary’s Hospital in the United Kingdom and the University of Connecticut in the United States. Dr. Kanth completed her fellowship in the specialty of Gastroenterology at the University of Utah, after which she joined the faculty as an Assistant Professor of Medicine.

Dr. Kanth specializes in the treatment, diagnosis, and continuing care of patients with esophageal disease, general gastrointestinal disorders and hereditary gastrointestinal cancer syndromes. Her research interests include the study of colon polyps, sessile serrated colon polyps, colon cancer prevention and high-risk familial gastrointestinal cancer. Dr. Kanth has received research and travel grants in support of her research work and has been published in peer-reviewed medical journals.

Education History

Graduate Training University of Utah
 MSCI
University of Utah Health Center
 Fellow
Chief Resident University of Connecticut Health Center
 Chief Medical Resident
University of Connecticut Health Center
 Resident
Residency St. Mary's Hospital, Isle of Wight Healthcare NHS Trust
 Resident
Royal Albert Edward Infirmary, Wigan and Leigh Trust
 Resident
Research Fellow All India Institute of Medical Sciences (AIIMS)
 Senior Research Fellow
Primary Health Center
 Senior House Officer
Internship Kasturba Medical College/Heavy Engineering Corporation Hospital
 Intern
Kasturba Medical College, Manipal Academy of Higher Education (MAHE) University
 MD

Selected Publications

Journal Article

  1. Kanth P, Yu Z, Keener MB, Koptiuch C, Kohlmann WK, Neklason DW, Westover M, Curtin K (2021). Cancer Risk in Patients With and Relatives of Serrated Polyposis Syndrome and Sporadic Sessile Serrated Lesions. Am J Gastroenterol, 117(2), 336-342.
  2. Kanth P, Yu Z, Keener MB, Koptiuch C, Kohlmann WK, Neklason DW, Westover M, Curtin K (2021). Cancer Risk in Patients With and Relatives of Serrated Polyposis Syndrome and Sporadic Sessile Serrated Lesions. Am J Gastroenterol.
  3. Weiss JM, Gupta S, Burke CA, Axell L, Chen LM, Chung DC, Clayback KM, Dallas S, Felder S, Gbolahan O, Giardiello FM, Grady W, Hall MJ, Hampel H, Hodan R, Idos G, Kanth P, Katona B, Lamps L, Llor X, Lynch PM, Markowitz AJ, Pirzadeh-Miller S, Samadder NJ, Shibata D, Swanson BJ, Szymaniak BM, Wiesner GL, Wolf A, Yurgelun MB, Zakhour M, Darlow SD, Dwyer MA, Campbell M (2021). NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021. J Natl Compr Canc Netw, 19(10), 1122-1132.
  4. Weiss JM, Gupta S, Burke CA, Axell L, Chen LM, Chung DC, Clayback KM, Dallas S, Felder S, Gbolahan O, Giardiello FM, Grady W, Hall MJ, Hampel H, Hodan R, Idos G, Kanth P, Katona B, Lamps L, Llor X, Lynch PM, Markowitz AJ, Pirzadeh-Miller S, Samadder NJ, Shibata D, Swanson BJ, Szymaniak BM, Wiesner GL, Wolf A, Yurgelun MB, Zakhour M, Darlow SD, Dwyer MA, Campbell M (2021). NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021. J Natl Compr Canc Netw, 19(10), 1122-1132.
  5. Kanth P, Inadomi JM (2021). Screening and prevention of colorectal cancer. BMJ, 374, n1855.
  6. Ochs-Balcom HM, Kanth P, Cannon-Albright LA (2021). Early-onset colorectal cancer risk extends to second- and third-degree relatives. Cancer Epidemiol, 73, 101973.
  7. Reyes-Uribe L, Wu W, Gelincik O, Bommi PV, Francisco-Cruz A, Solis LM, Lynch PM, Lim R, Stoffel EM, Kanth P, Samadder NJ, Mork ME, Taggart MW, Milne GL, Marnett LJ, Vornik L, Liu DD, Revuelta M, Chang K, You YN, Kopelovich L, Wistuba II, Lee JJ, Sei S, Shoemaker RH, Szabo E, Richmond E, Umar A, Perloff M, Brown PH, Lipkin SM, Vilar E (2020). Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa. Gut, 70(3), 555-566.
  8. Ochs-Balcom HM, Kanth P, Farnham JM, Abdelrahman S, Cannon-Albright LA (2020). Colorectal cancer risk based on extended family history and body mass index. Genet Epidemiol, 44(7), 778-784.
  9. Provenzale D, Ness RM, Llor X, Weiss JM, Abbadessa B, Cooper G, Early DS, Friedman M, Giardiello FM, Glaser K, Gurudu S, Halverson AL, Issaka R, Jain R, Kanth P, Kidambi T, Lazenby AJ, Maguire L, Markowitz AJ, May FP, Mayer RJ, Mehta S, Patel S, Peter S, Stanich PP, Terdiman J, Keller J, Dwyer MA, Ogba N (2020). NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020. J Natl Compr Canc Netw, 18(10), 1312-1320.
  10. Burke CA, Dekker E, Lynch P, Samadder NJ, Balaguer F, Hneburg R, Burn J, Castells A, Gallinger S, Lim R, Stoffel EM, Gupta S, Henderson A, Kallenberg FG, Kanth P, Roos VH, Ginsberg GG, Sinicrope FA, Strassburg CP, Van Cutsem E, Church J, Lalloo F, Willingham FF, Wise PE, Grady WM, Ford M, Weiss JM, Gryfe R, Rustgi AK, Syngal S, Cohen A (2020). Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis. N Engl J Med, 383(11), 1028-1039.
  11. Kanth P, Boylan KE, Bronner MP, Boucher KM, Hazel MW, Yao R, Pop S, Bernard PS, Delker DA (2019). Molecular Biomarkers of Sessile Serrated Adenoma/Polyps. Clin Transl Gastroenterol, 10(12), e00104.
  12. Gupta S, Provenzale D, Llor X, Halverson AL, Grady W, Chung DC, Haraldsdottir S, Markowitz AJ, Slavin TP Jr, Hampel H, CGC, Ness RM, Weiss JM, Ahnen DJ, Chen LM, Cooper G, Early DS, Giardiello FM, Hall MJ, Hamilton SR, Kanth P, Klapman JB, Lazenby AJ, Lynch PM, Mayer RJ, Mikkelson J, CGC, Peter S, Regenbogen SE, Dwyer MA, CGC, Ogba N (2019). NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019. J Natl Compr Canc Netw, 17(9), 1032-1041.
  13. Ashktorab H, Delker D, Kanth P, Goel A, Carethers JM, Brim H (2019). Molecular Characterization of Sessile Serrated Adenoma/Polyps From a Large African American Cohort. Gastroenterology, 157(2), 572-574.
  14. Kanth P, Hazel MW, Boucher KM, Yang Z, Wang L, Bronner MP, Boylan KE, Burt RW, Westover M, Neklason DW, Delker DA (2018). Small RNA sequencing of sessile serrated polyps identifies microRNA profile associated with colon cancer. Genes Chromosomes Cancer, 58(1), 23-33.
  15. Chang K, Willis JA, Reumers J, Taggart MW, San Lucas FA, Thirumurthi S, Kanth P, Delker DA, Hagedorn CH, Lynch PM, Ellis LM, Hawk ET, Scheet PA, Kopetz S, Arts J, Guinney J, Dienstmann R, Vilar E (2018). Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2. Ann Oncol, 29(10), 2061-2067.
  16. Sample DC, Samadder NJ, Pappas LM, Boucher KM, Samowitz WS, Berry T, Westover M, Nathan D, Kanth P, Byrne KR, Burt RW, Neklason DW (2018). Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients. BMC Gastroenterol, 18(1), 115.
  17. Kanth P, Affolter K (2018). Worming Your Way Through the Gastrointestinal Tract: A Case of Strongyloidiasis. Clin Gastroenterol Hepatol, 16(7), A33.
  18. Samadder NJ, Kuwada SK, Boucher KM, Byrne K, Kanth P, Samowitz W, Jones D, Tavtigian SV, Westover M, Berry T, Jasperson K, Pappas L, Smith L, Sample D, Burt RW, Neklason DW (2018). Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol, 4(5), 671-677.
  19. Caliskan A, Kohlmann WK, Affolter KE, Downs-Kelly E, Kanth P, Bronner MP (2017). Intramucosal lipomas of the colon implicate Cowden syndrome. Mod Pathol, 31(4), 643-651.
  20. Delker DA, Wood AC, Snow AK, Samadder NJ, Samowitz WS, Affolter KE, Boucher KM, Pappas LM, Stijleman IJ, Kanth P, Byrne KR, Burt RW, Bernard PS, Neklason DW (2017). Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia. Cancer Prev Res (Phila), 11(1), 4-15.
  21. Kanth P, Grimmett J, Champine M, Burt R, Samadder NJ (2017). Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management. Am J Gastroenterol, 112(10), 1509-1525.
  22. Schell JC, Wisidagama DR, Bensard C, Zhao H, Wei P, Tanner J, Flores A, Mohlman J, Sorensen LK, Earl CS, Olson KA, Miao R, Waller TC, Delker D, Kanth P, Jiang L, DeBerardinis RJ, Bronner MP, Li DY, Cox JE, Christofk HR, Lowry WE, Thummel CS, Rutter J (2017). Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism. Nat Cell Biol, 19(9), 1027-1036.
  23. Schell JC, Wisidagama DR, Bensard C, Zhao H, Wei P, Tanner J, Flores A, Mohlman J, Sorensen LK, Earl CS, Olson KA, Miao R, Waller TC, Delker D, Kanth P, Jiang L, DeBerardinis RJ, Bronner MP, Li DY, Cox JE, Christofk HR, Lowry WE, Thummel CS, Rutter J (8/31/2017). Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism. Nat Cell Biol.
  24. Kanth P, Bronner MP, Boucher KM, Burt RW, Neklason DW, Hagedorn CH, Delker DA (2016). Gene Signature in Sessile Serrated Polyps Identifies Colon Cancer Subtype. Cancer Prev Res (Phila), 9(6), 456-65.
  25. Samadder NJ, Neklason DW, Boucher KM, Byrne KR, Kanth P, Samowitz W, Jones D, Tavtigian SV, Done MW, Berry T, Jasperson K, Pappas L, Smith L, Sample D, Davis R, Topham MK, Lynch P, Strait E, McKinnon W, Burt RW, Kuwada SK (2016). Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial. JAMA, 315(12), 1266-75.
  26. Delker DA, McGettigan BM, Kanth P, Pop S, Neklason DW, Bronner MP, Burt RW, Hagedorn CH (2014). RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers. PLoS One, 9(2), e88367.
  27. Jasperson KW, Kanth P, Kirchhoff AC, Huismann D, Gammon A, Kohlmann W, Burt RW, Samadder NJ (2013). Serrated polyposis: colonic phenotype, extracolonic features, and familial risk in a large cohort. Dis Colon Rectum, 56(11), 1211-6.
  28. Kanth P, Fang J (2012). Cerebral air embolism: a complication of a bleeding atrioesophageal fistula. Clin Gastroenterol Hepatol, 10(3), A22.
  29. Kanth P, Go MF (2011). Squamous papilloma: an unusual esophageal entity. Endoscopy, 43 Suppl 2 UCTN, E405-6.
  30. Kanth P, Tendler B, Forouhar F (March/April, 2008). A case of thyroid storm with underlying thyroid carcinoma. Endocrinologist, 18(2), 62-84.

Review

  1. Lindsey Bierle, Priyanka Kanth (2020). Advanced Imaging in Hereditary Colon Cancer Syndromes. [Review]. Pract Gastroenterol, XLIV(1), 26-36.

Conference Proceedings

  1. Kanth P, Bronner M, et al (October 2016). Small Non-coding RNA Transcriptome in Sessile Serrated Colon Polyps. American College of Gastroenterology Meeting, Las Vegas.
  2. Kanth P, et al (October 2016). Use of a Hereditary Cancer Risk Assessment Tool for Patients Undergoing Upper Endoscopy and Colonoscopy: A Quality Improvement Project from a Large Tertiary Care Center (Presidential poster winner). American College of Gastroenterology Meeting, Las Vegas.
  3. Delker DA, Kanth P, et al (May 2013). Next Generation Sequencing Analysis of 5' Capped RNAs Identifires Novel Differentially Expressed Genes in Sessile Serrated Colon Polyps. Gastroenterology, Orlando, FL: Digestive Disease Week, 144(5), S-526.
  4. Kanth P, Stayner JL, Samadder NJ (2012). Cytotoxic T-lymphocyte-Associated Antigen 4 antibody (lpilimumab) associated Enterocolitis. American College of Gastroenterology Meeting, Las Vegas.
  5. Kanth P, Peterson K, Boynton K (2012). More Bumps in the Road for IBD: Prevalence and risk factors for sporadic polyps in an IBD cohort. Gastroenterology, San Diego: Digestive Disease Week, 142(3), S-635-S-636.
  6. Kanth P, Rajan TV (2011). Chromogranin A and Ki67 expression in Normal Colon, Serrated Polyps and Colorectal Tubular Adenomas. American College of Gastroenterology Meeting, Washington, D.C..
  7. Kanth P, Hegde P, Rajan TV (2009). Inter-observer variability in re-evaluation of a diagnosis of "Hyperplastic polyp". Gastroenterology, Chicago, IL: Digestive Disease Week, 136(5), A-768.
  8. Kanth P, Wilkinson L, Levine J, Sanders M, Rajan TV (2008). Re­evaluation of diagnosis of 'benign' colon polyp. American College of Gastroenterology Meeting, Orlando, Florida.
  9. Kanth P, Huang T, Tian J, Nagar AB (2008). Patients with diabetes mellitus, elevated cholesterol and increased BMI while on medications do not have an increased risk of Colorectal Adenoma. American College of Gastroenterology Meeting, Orlando, Florida.
  10. Kanth P, Thumar J, et al (2008). Cytomegalovirus colitis in an immune­competent patient: Review of Endoscopy findings. American College of Gastroenterology Meeting, Orlando, Florida.
  11. Kanth P, Thumar J (2007). Transverse colon diverticulitis: Literature review. American College of Physicians Meeting, Southington, Connecticut.

Editorial

  1. Kanth P, Samadder NJ, DiSario J (2017). Duodenal adenomas in sporadic and familial adenomatous polyposis patients: Birds of a feather? Gastrointest Endosc, 85(4), 813-815.

Abstract

  1. Kanth P, Boylan K et al (2017). Evaluation of a gene expression panel for diagnosis of sessile serrated adenoma/polyps: Report from a large tertiary health care system. [Abstract]. Gastroenterology, 152(5), S539-540.
  2. Kanth P, Bronner MP, Boucher KM, Burt R, Neklason DW, Hagedorn CH, Delker DA (2015). RNA sequencing identifies unique and commonly expressed genes in sessile serrated and hyperplastic colon polyps and demonstrates molecular overlap between syndromic and sporadic sessile serrated polyps [Abstract]. Gastroenterology, 148(4), S-363.

Patent

  1. Don DELKER, Priyanka KANTH (2017). Methods and compositions for predicting a colon cancer subtype. U.S. Patent No. WO 2017132139 A1. Washington, D.C.:U.S. Patent and Trademark Office.